Management of spasticity in children with cerebral palsy

Ann Tilton1

  • 1Department of Neurology, Louisiana State University Health and Sciences Center, New Orleans, LA 70118, USA. atilto@aol.com

Insights

Treatments for cerebral palsy spasticity aim to improve function and comfort. Options range from therapies and medications to surgery, often combined for best results in children.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Orthopedic Surgery

Background:

  • Cerebral palsy (CP) frequently causes spasticity and muscle overactivity.
  • This muscle overactivity can significantly impair a child's function, ease of care, comfort, and body image.
  • Effective management is crucial for improving quality of life in children with CP.

Purpose of the Study:

  • To provide a comprehensive overview of current treatment strategies for spasticity in cerebral palsy.
  • To review significant research findings supporting the efficacy of various interventions.
  • To guide clinicians in selecting and combining treatments tailored to individual pediatric needs.

Main Methods:

  • Review of established and emerging treatment modalities for pediatric cerebral palsy spasticity.
  • Inclusion of allied health therapies, exercise, casting, and constraint-induced therapy.
  • Analysis of pharmacological and surgical interventions including chemodenervation, intrathecal baclofen, selective dorsal rhizotomy, and orthopedic surgery.

Main Results:

  • Each treatment approach has demonstrated varying degrees of efficacy in managing spasticity.
  • Combination therapies often yield superior outcomes compared to single interventions.
  • Evidence supports the tailored application of treatments based on individual patient profiles and needs.

Conclusions:

  • A multimodal approach is often necessary for optimal management of cerebral palsy spasticity.
  • Interdisciplinary collaboration is key to integrating diverse treatment strategies effectively.
  • Continued research is vital to refine existing treatments and explore novel therapeutic avenues.

Related Concept Videos

Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...